Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Memory Enhancement Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Memory Enhancement Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Aricept 1.4.3 Razadyne 1.4.4 Namenda 1.4.5 Exelon 1.4.6 Provigil 1.4.7 Ritalin 1.4.8 Adderall 1.4.9 Others 1.5 Market by Application 1.5.1 Global Memory Enhancement Drugs Market Share by Application: 2020 VS 2026 1.5.2 Disease Treatment 1.5.3 Academic Performance 1.5.4 Athletic Performance 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Memory Enhancement Drugs Market Perspective (2015-2026) 2.2 Memory Enhancement Drugs Growth Trends by Regions 2.2.1 Memory Enhancement Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Memory Enhancement Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Memory Enhancement Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Memory Enhancement Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Memory Enhancement Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Memory Enhancement Drugs Players by Market Size 3.1.1 Global Top Memory Enhancement Drugs Players by Revenue (2015-2020) 3.1.2 Global Memory Enhancement Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Memory Enhancement Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Memory Enhancement Drugs Market Concentration Ratio 3.2.1 Global Memory Enhancement Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Memory Enhancement Drugs Revenue in 2019 3.3 Memory Enhancement Drugs Key Players Head office and Area Served 3.4 Key Players Memory Enhancement Drugs Product Solution and Service 3.5 Date of Enter into Memory Enhancement Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Memory Enhancement Drugs Historic Market Size by Type (2015-2020) 4.2 Global Memory Enhancement Drugs Forecasted Market Size by Type (2021-2026) 5 Memory Enhancement Drugs Breakdown Data by Application (2015-2026) 5.1 Global Memory Enhancement Drugs Market Size by Application (2015-2020) 5.2 Global Memory Enhancement Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Memory Enhancement Drugs Market Size (2015-2020) 6.2 Memory Enhancement Drugs Key Players in North America (2019-2020) 6.3 North America Memory Enhancement Drugs Market Size by Type (2015-2020) 6.4 North America Memory Enhancement Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Memory Enhancement Drugs Market Size (2015-2020) 7.2 Memory Enhancement Drugs Key Players in Europe (2019-2020) 7.3 Europe Memory Enhancement Drugs Market Size by Type (2015-2020) 7.4 Europe Memory Enhancement Drugs Market Size by Application (2015-2020) 8 China 8.1 China Memory Enhancement Drugs Market Size (2015-2020) 8.2 Memory Enhancement Drugs Key Players in China (2019-2020) 8.3 China Memory Enhancement Drugs Market Size by Type (2015-2020) 8.4 China Memory Enhancement Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Memory Enhancement Drugs Market Size (2015-2020) 9.2 Memory Enhancement Drugs Key Players in Japan (2019-2020) 9.3 Japan Memory Enhancement Drugs Market Size by Type (2015-2020) 9.4 Japan Memory Enhancement Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Memory Enhancement Drugs Market Size (2015-2020) 10.2 Memory Enhancement Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Memory Enhancement Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Memory Enhancement Drugs Market Size by Application (2015-2020) 11 India 11.1 India Memory Enhancement Drugs Market Size (2015-2020) 11.2 Memory Enhancement Drugs Key Players in India (2019-2020) 11.3 India Memory Enhancement Drugs Market Size by Type (2015-2020) 11.4 India Memory Enhancement Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Memory Enhancement Drugs Market Size (2015-2020) 12.2 Memory Enhancement Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Memory Enhancement Drugs Market Size by Type (2015-2020) 12.4 Central & South America Memory Enhancement Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Memory Enhancement Drugs Introduction 13.1.4 Pfizer Revenue in Memory Enhancement Drugs Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview and Its Total Revenue 13.2.3 Novartis Memory Enhancement Drugs Introduction 13.2.4 Novartis Revenue in Memory Enhancement Drugs Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 Shire Pharmaceuticals 13.3.1 Shire Pharmaceuticals Company Details 13.3.2 Shire Pharmaceuticals Business Overview and Its Total Revenue 13.3.3 Shire Pharmaceuticals Memory Enhancement Drugs Introduction 13.3.4 Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) 13.3.5 Shire Pharmaceuticals Recent Development 13.4 Allergan Plc 13.4.1 Allergan Plc Company Details 13.4.2 Allergan Plc Business Overview and Its Total Revenue 13.4.3 Allergan Plc Memory Enhancement Drugs Introduction 13.4.4 Allergan Plc Revenue in Memory Enhancement Drugs Business (2015-2020) 13.4.5 Allergan Plc Recent Development 13.5 Cephalon 13.5.1 Cephalon Company Details 13.5.2 Cephalon Business Overview and Its Total Revenue 13.5.3 Cephalon Memory Enhancement Drugs Introduction 13.5.4 Cephalon Revenue in Memory Enhancement Drugs Business (2015-2020) 13.5.5 Cephalon Recent Development 13.6 AlternaScript 13.6.1 AlternaScript Company Details 13.6.2 AlternaScript Business Overview and Its Total Revenue 13.6.3 AlternaScript Memory Enhancement Drugs Introduction 13.6.4 AlternaScript Revenue in Memory Enhancement Drugs Business (2015-2020) 13.6.5 AlternaScript Recent Development 13.7 Takeda Pharmaceutical Company 13.7.1 Takeda Pharmaceutical Company Company Details 13.7.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue 13.7.3 Takeda Pharmaceutical Company Memory Enhancement Drugs Introduction 13.7.4 Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2015-2020) 13.7.5 Takeda Pharmaceutical Company Recent Development 13.8 Eisai 13.8.1 Eisai Company Details 13.8.2 Eisai Business Overview and Its Total Revenue 13.8.3 Eisai Memory Enhancement Drugs Introduction 13.8.4 Eisai Revenue in Memory Enhancement Drugs Business (2015-2020) 13.8.5 Eisai Recent Development 13.9 Barr Pharmaceuticals 13.9.1 Barr Pharmaceuticals Company Details 13.9.2 Barr Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Barr Pharmaceuticals Memory Enhancement Drugs Introduction 13.9.4 Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) 13.9.5 Barr Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Memory Enhancement Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Memory Enhancement Drugs Revenue Table 3. Ranking of Global Top Memory Enhancement Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Memory Enhancement Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Aricept Table 6. Key Players of Razadyne Table 7. Key Players of Namenda Table 8. Key Players of Exelon Table 9. Key Players of Provigil Table 10. Key Players of Ritalin Table 11. Key Players of Adderall Table 12. Key Players of Others Table 13. Global Memory Enhancement Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Memory Enhancement Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Memory Enhancement Drugs Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Memory Enhancement Drugs Market Share by Regions (2015-2020) Table 17. Global Memory Enhancement Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Memory Enhancement Drugs Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Memory Enhancement Drugs Market Growth Strategy Table 23. Main Points Interviewed from Key Memory Enhancement Drugs Players Table 24. Global Memory Enhancement Drugs Revenue by Players (2015-2020) (Million US$) Table 25. Global Memory Enhancement Drugs Market Share by Players (2015-2020) Table 26. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2019) Table 27. Global Memory Enhancement Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Memory Enhancement Drugs Product Solution and Service Table 30. Date of Enter into Memory Enhancement Drugs Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 33. Global Memory Enhancement Drugs Market Size Share by Type (2015-2020) Table 34. Global Memory Enhancement Drugs Revenue Market Share by Type (2021-2026) Table 35. Global Memory Enhancement Drugs Market Size Share by Application (2015-2020) Table 36. Global Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 37. Global Memory Enhancement Drugs Market Size Share by Application (2021-2026) Table 38. North America Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 39. North America Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 40. North America Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 41. North America Memory Enhancement Drugs Market Share by Type (2015-2020) Table 42. North America Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 43. North America Memory Enhancement Drugs Market Share by Application (2015-2020) Table 44. Europe Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 46. Europe Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 47. Europe Memory Enhancement Drugs Market Share by Type (2015-2020) Table 48. Europe Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 49. Europe Memory Enhancement Drugs Market Share by Application (2015-2020) Table 50. China Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 51. China Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 52. China Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 53. China Memory Enhancement Drugs Market Share by Type (2015-2020) Table 54. China Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 55. China Memory Enhancement Drugs Market Share by Application (2015-2020) Table 56. Japan Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 57. Japan Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 58. Japan Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 59. Japan Memory Enhancement Drugs Market Share by Type (2015-2020) Table 60. Japan Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 61. Japan Memory Enhancement Drugs Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 64. Southeast Asia Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia Memory Enhancement Drugs Market Share by Type (2015-2020) Table 66. Southeast Asia Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia Memory Enhancement Drugs Market Share by Application (2015-2020) Table 68. India Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 69. India Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 70. India Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 71. India Memory Enhancement Drugs Market Share by Type (2015-2020) Table 72. India Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 73. India Memory Enhancement Drugs Market Share by Application (2015-2020) Table 74. Central & South America Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players Memory Enhancement Drugs Market Share (2019-2020) Table 76. Central & South America Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America Memory Enhancement Drugs Market Share by Type (2015-2020) Table 78. Central & South America Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America Memory Enhancement Drugs Market Share by Application (2015-2020) Table 80. Pfizer Company Details Table 81. Pfizer Business Overview Table 82. Pfizer Product Table 83. Pfizer Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 84. Pfizer Recent Development Table 85. Novartis Company Details Table 86. Novartis Business Overview Table 87. Novartis Product Table 88. Novartis Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 89. Novartis Recent Development Table 90. Shire Pharmaceuticals Company Details Table 91. Shire Pharmaceuticals Business Overview Table 92. Shire Pharmaceuticals Product Table 93. Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 94. Shire Pharmaceuticals Recent Development Table 95. Allergan Plc Company Details Table 96. Allergan Plc Business Overview Table 97. Allergan Plc Product Table 98. Allergan Plc Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 99. Allergan Plc Recent Development Table 100. Cephalon Company Details Table 101. Cephalon Business Overview Table 102. Cephalon Product Table 103. Cephalon Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 104. Cephalon Recent Development Table 105. AlternaScript Company Details Table 106. AlternaScript Business Overview Table 107. AlternaScript Product Table 108. AlternaScript Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 109. AlternaScript Recent Development Table 110. Takeda Pharmaceutical Company Company Details Table 111. Takeda Pharmaceutical Company Business Overview Table 112. Takeda Pharmaceutical Company Product Table 113. Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 114. Takeda Pharmaceutical Company Recent Development Table 115. Eisai Business Overview Table 116. Eisai Product Table 117. Eisai Company Details Table 118. Eisai Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 119. Eisai Recent Development Table 120. Barr Pharmaceuticals Company Details Table 121. Barr Pharmaceuticals Business Overview Table 122. Barr Pharmaceuticals Product Table 123. Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$) Table 124. Barr Pharmaceuticals Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Memory Enhancement Drugs Market Share by Type: 2020 VS 2026 Figure 2. Aricept Features Figure 3. Razadyne Features Figure 4. Namenda Features Figure 5. Exelon Features Figure 6. Provigil Features Figure 7. Ritalin Features Figure 8. Adderall Features Figure 9. Others Features Figure 10. Global Memory Enhancement Drugs Market Share by Application: 2020 VS 2026 Figure 11. Disease Treatment Case Studies Figure 12. Academic Performance Case Studies Figure 13. Athletic Performance Case Studies Figure 14. Others Case Studies Figure 15. Memory Enhancement Drugs Report Years Considered Figure 16. Global Memory Enhancement Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 17. Global Memory Enhancement Drugs Market Share by Regions: 2020 VS 2026 Figure 18. Global Memory Enhancement Drugs Market Share by Regions (2021-2026) Figure 19. Porter's Five Forces Analysis Figure 20. Global Memory Enhancement Drugs Market Share by Players in 2019 Figure 21. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2019 Figure 22. The Top 10 and 5 Players Market Share by Memory Enhancement Drugs Revenue in 2019 Figure 23. North America Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Europe Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. China Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Japan Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Southeast Asia Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 28. India Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Central & South America Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Pfizer Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Novartis Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 34. Shire Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Shire Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 36. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Allergan Plc Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 38. Cephalon Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Cephalon Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 40. AlternaScript Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. AlternaScript Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 42. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Takeda Pharmaceutical Company Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 44. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Eisai Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 46. Barr Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Barr Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Pfizer Novartis Shire Pharmaceuticals Allergan Plc Cephalon AlternaScript Takeda Pharmaceutical Company Eisai Barr Pharmaceuticals